Dovitinib
Dovitinib is an orally bioavailable small molecule that inhibits multiple receptor tyrosine kinases (RTKs) . It has demonstrated anti-tumor activity in preclinical research, including in vitro cell proliferation assays and in vivo xenograft models, supporting its investigation in oncology.
Product Specifications
CAS Number
405169-16-6
Product Name Alternative
TKI-258; CHIR258
Field of Research
Cardiovascular Research, Cell Biology
Purity
>98%
Form
Powder
Solubility
Soluble in DMSO (up to 30 mg/ml) .
Smiles
CN1CCN (CC1) c1ccc2nc ([nH]c2c1) -c1c (N) c2c (F) cccc2[nH]c1=O
Molecular Formula
C21H21FN6O
Molecular Weight
392.4
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
4-Amino-5-fluoro-3-[5- (4-methylpiperazin-1-yl) -1H-benzimidazol-2-yl]quinolin-2 (1H) -one
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
